The use of immunotherapy and/or targeted drugs revolutionized the treatment of many cancers, but some people grow resistant to immunotherapy drugs and relapse as a result.
Apr 22, 2022
0
84
Cancer researchers at the University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, and at the Medical Faculty of Kiel University have described approaches for improved therapy of adult blood cancer patients in a ...
Apr 21, 2022
0
28
Researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health, with collaborators at La Jolla Institute for Immunology and elsewhere, have further elucidated how ovarian ...
Apr 11, 2022
0
41
Adding the immunotherapy drug nivolumab to chemotherapy before surgery (neoadjuvant) for patients with operable non-small cell lung cancer (NSCLC)—the leading cause of cancer deaths worldwide—reduced the risk of recurrence ...
Apr 11, 2022
0
3
Two Roswell Park Comprehensive Cancer Center oncologists will discuss promising strategies for making breakthrough immunotherapies work for more patients at the annual meeting of the American Association for Cancer Research ...
Apr 11, 2022
0
14
Findings from a new study performed in mice suggest that omega-3 fatty acids could help immunotherapy and other treatments do a better job at fighting cancer. Immunotherapies, which stimulate the body's own immune system ...
Apr 1, 2022
0
17
Queensland research is providing new hope to immunocompromised people who are vulnerable to COVID-19. Scientists from QIMR Berghofer have discovered promising evidence that T cell immunotherapy could help them to fight against ...
Mar 22, 2022
0
20
A study published in the journal Nature Cancer, carried out within the Cancer Program at the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar) by the Cancer Stem Cells and Metastasis Dynamics Laboratory, ...
Mar 17, 2022
0
143
For years, surgery for patients with stage III melanoma—melanoma that has spread to the lymph nodes—involved removing those lymph nodes along with the primary tumor. Known as completion lymph node dissection (CLND), the ...
Mar 4, 2022
0
4
Researchers at the University of Michigan Rogel Cancer Center found that a cytokine, a category of protein that acts as messengers in the body, and a fatty acid can work together to trigger a type of cell death previously ...
Mar 4, 2022
0
105
